Shares of Hunting PLC (LON:HTG – Get Free Report) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 392.89 ($5.26) and traded as high as GBX 396.11 ($5.30). Hunting shares last traded at GBX 382 ($5.12), with a volume of 386,060 shares.
Analyst Ratings Changes
Several brokerages have weighed in on HTG. Canaccord Genuity Group reaffirmed a “buy” rating and set a GBX 600 ($8.03) target price on shares of Hunting in a research note on Thursday, August 29th. Shore Capital reaffirmed a “buy” rating and issued a GBX 510 ($6.83) price objective on shares of Hunting in a report on Wednesday, June 12th. Finally, Berenberg Bank reissued a “buy” rating and set a GBX 520 ($6.96) target price on shares of Hunting in a research note on Thursday, August 29th.
Get Our Latest Stock Analysis on Hunting
Hunting Trading Down 4.0 %
Hunting Increases Dividend
The firm also recently announced a dividend, which will be paid on Friday, October 25th. Investors of record on Thursday, October 3rd will be paid a dividend of $0.06 per share. The ex-dividend date of this dividend is Thursday, October 3rd. This is a positive change from Hunting’s previous dividend of $0.05. This represents a yield of 0.97%. Hunting’s dividend payout ratio is currently 1,333.33%.
About Hunting
Hunting PLC, together with its subsidiaries, manufactures components, technology systems, and precision parts worldwide. It operates in five segments: Hunting Titan; North America; Subsea Technologies; EMEA; and Asia Pacific. The company designs and manufactures perforating systems, energetics, instrumentation, and associated hardware; connection technology and OCTG; subsea technologies; supplies highly engineered tubular components, hollow rotating shafts, very accurate deep hole drilling, plus complex turned, and milled profiles; well intervention equipment; and well test and process systems.
Featured Articles
- Five stocks we like better than Hunting
- Financial Services Stocks Investing
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- P/E Ratio Calculation: How to Assess Stocks
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- 3 Tickers Leading a Meme Stock Revival
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Hunting Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hunting and related companies with MarketBeat.com's FREE daily email newsletter.